Pregled bibliografske jedinice broj: 1198106
Patch testing with methylchloroisothiazolinone/methylisothiazolinone using a new diagnostic mix - a multicenter study from the international contact dermatitis research group
Patch testing with methylchloroisothiazolinone/methylisothiazolinone using a new diagnostic mix - a multicenter study from the international contact dermatitis research group // Dermatitis, 32 (2021), 4; 220-224 doi:10.1097/DER.0000000000000657 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1198106 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Patch testing with
methylchloroisothiazolinone/methylisothiazolinone
using a new diagnostic mix - a
multicenter study from the international contact
dermatitis research group
(Patch testing with methylchloroisothiazolinone/methylisothiazolinone using a
new diagnostic mix - a
multicenter study from the international contact dermatitis research group)
Autori
Isaksson, Marléne ; Andersen, Klaus E ; Cannavó, Alicia ; Elsner, Peter ; Goh, Chee-Leok ; Gonçalo, Margarida ; Goossens, An ; Ljubojević Hadžavdić, Suzana ; Pratt, Melanie ; Puangpet, Pailin ; Sasseville, Denis ; Verma , Kaushal ; Bruze, Magnus
Izvornik
Dermatitis (1710-3568) 32
(2021), 4;
220-224
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
multicenter study ; patch testing ; methylchloroisothiazolinone ; new diagnostic mix
Sažetak
Background: In the early 1980s, a preservative containing a mixture of methylchloroisothiazolinone (MCI) and methylisothiazolinone (MI) in a ratio of 3:1 was introduced. This mixture (mix) has been patch tested at 100 ppm (0.01%) worldwide and at 200 ppm (0.02%) in Sweden since 1986 and also in the European baseline series since 2014. Objective: A new aqueous mix of MCI 0.015% and MI 0.2% was compared with patch testing with the 2 aqueous baseline preparations of MCI/MI 0.02% and MI 0.2%. Methods: Four thousand three hundred ninety-seven patients with dermatitis in 12 International Contact Dermatitis Research Group dermatology departments from 3 continents were patch tested simultaneously with the 3 preparations. Results: The frequency of positive patch tests to the allergens varied between 0% and 26.7% in the 12 test centers. The new mixture MCI/MI 0.215% in aqua (aq) detected significantly more patients with MCI/MI allergy than both MCI/MI 0.02% aq (P < 0.001) and MI 0.2% aq (P < 0.001) alone and combined. Conclusions: The results favor replacing the preparations MCI/MI 0.02% aq and MI 0.2% aq with the mixture MCI/MI 0.215% aq in the International Contact Dermatitis Research Group baseline series.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Suzana Ljubojević Hadžavdić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE